Knowledge Distillery

Serum neurofilament light chain (sNfL) is an established biomarker of neuro-axonal damage in multiple neurological disorders.

SARS-CoV-2 vaccine rollout has coincided with the spread of variants of concern. In this article the authors investigated if single dose vaccination,…

The understanding of risk factors for COVID‑19, including pre-existing medical conditions and genetic variations, is limited. To what extent the…

The aim of this case-control study was to determine which characteristics and outcomes of stroke are associated with COVID-19. The study included…

In this paper, the authors evaluated incidence and clinical features of Guillain-Barre syndrome (GBS) in a cohort of patients from two regions of…

The aim of the study was to assess the risk of hospitalisation for COVID‐19 and death in a cohort of patients with Parkinson’s disease or Parkinsonism…

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have been postulated to affect susceptibility to COVID-19.…

In this paper recently published in the European Journal of Neurology, the authors aimed to determine the frequency and distribution of currently…

Case fatality rates (CFR) of the novel 2019 coronavirus disease (COVID-19) have been reported ranging between 0% to 40% among Parkinson’s disease (PD)…

The objective of this study was to evaluate patient perspectives regarding the use of natalizumab and anti-CD20 therapies (rituximab and ocrelizumab)…

The objective of this study, recently published in Journal of Parkinson’s Disease, was to rapidly identify areas of need to help improve care in…

The objective of this case-control study was to estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S…